Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model
Open Access
- 1 May 2016
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 31 (5) , 308-313
Abstract
To evaluate a modified experimental model for medication-related osteonecrosis of the jaw (MRONJ) through the upper right central incisor extraction followed by intravenous bisphosphonate administration. Forty five rats underwent the upper right central incisor tooth extraction were divided in 2 groups: Group I - experimental group, 30 rats received an intravenous administration protocol of zoledronic acid 35μg/kg into the tail vein every two weeks, totalizing four administrations, during eight weeks of administration, previously the extraction, and Group II - control group, 15 rats didn't received any medication before extraction. The groups were subdivided in postoperative periods: 14/28/42 days. Clinical analysis and microtomography were performed to verify the presence of osteonecrosis. In addition, descritive histological analysis of hematoxylin-eosin stained sections was performed to evaluate the presence of osteonecrosis or necrotic foci. Twelve (40%) rats, from experimental group, showed clinical signs of MRONJ (p=0.005), however, all samples showed imaginologic findings like osteolysis and loss of integrity of the cellular walls (p≤0.001). Microscopic evaluation revealed osteonecrosis areas with microbial colonies and inflammatory infiltrate (p≤0.001). In the control group, all animals presented the chronology of a normal wound healing. The presence of medication-related osteonecrosis of the jaw after maxillary central incisor extraction in rats. This new experimental model may be considered an option for the study of MRONJ.Keywords
This publication has 40 references indexed in Scilit:
- Radiographic evaluation of maxillofacial region in oncology patients treated with bisphosphonatesOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2012
- Physiology of the aging bone and mechanisms of action of bisphosphonatesBiogerontology, 2011
- Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the ratJournal of Bone and Mineral Research, 2011
- Bisphosphonates Cause Osteonecrosis of the Jaw-Like Disease in MiceThe American Journal of Pathology, 2010
- Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in ratsJournal of Bone and Mineral Research, 2010
- Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogsJournal of Bone and Mineral Research, 2010
- Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in miceJournal of Bone and Mineral Metabolism, 2009
- Bisphosphonates: Mechanism of Action and Role in Clinical PracticeMayo Clinic Proceedings, 2008
- Mandible Matrix Necrosis in Beagle Dogs After 3 Years of Daily Oral Bisphosphonate TreatmentJournal of Oral and Maxillofacial Surgery, 2008
- Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?Bone, 2007